Our objective is to characterize leukocyte surface receptors for endothelium (LRE), and to define their role in lymphocyte traffic and leukocyte extravasation in sites of inflammation. 1) We will examine the expression of LRE by defined human lymphocyte subsets using a) a functional in vitro assay of lymphocyte binding to high endothelial venules (HEV, specialized venules that mediate the migration of lymphocytes from the blood); and b) FACS analyses of cells stained with a monoclonal antibody (Hermes-1) against human LRE. 2) Human lymphocyte LRE will be characterized structurally in immunoprecipitation/gel analyses, and functionally by their mimicry of or their effect on lymphocyte-HEV interaction in vitro. 3) We have found that mouse neutrophils utilize molecules similar if not identical to lymphocyte LRE to interact with endothelial cells in vitro (in the frozen section model) and in vivo during migration into acute inflammatory sites. By using fluorescence and immunoprecipitation analyses with Hermes-1 and MEL-14 (anti-mouse lymphocyte receptor for lymph node HEV), in combination with functional in vitro assays of binding to endothelial cells, we will ask whether monocytes, natural killer cells (LGL), mast cells and other leukocytes (or cell lines) utilize similar molecules to interact with endothelium. FACS analyses will be used to study the regulation of LRE during leukocyte maturation, differentiation, and activation. 4) To understand the site-specific extravasation of neutrophils versus lymphocytes, we will a) explore the role of leukocyte and/or endothelial cell activation in lymphocyte and neutrophil interactions with endothelium; b) study functionally defined factor(s) that enhance lymphocyte-HEV interaction; and c) seek structural and functional differences between lymphocyte and neutrophil LRE. 5) To define mechanisms controlling lymphocyte traffic into inflamed extralymphoid tissues, we will use in vitro and in vivo assays to examine the function and specificity of HEV in sites of chronic inflammation in pathologic specimens (inflamed skin, rheumatoid synovium) and in CFA-induced granulomas in mice. Preliminary studies indicate that a novel receptor class (distinct from organ-specific receptor systems operating in lymph nodes and mucosal lymphoid tissues) may direct lymphocyte traffic into inflamed synovium, if so we will attempt to define these receptors by producing monoclonal antibodies capable of blocking lymphocyte interactions with synovial HEV. These studies will improve our understanding of normal and pathologic inflammatory responses. They have the potential to lead to site-selective means for controlling localized inflammatory/autoimmune disease processes. In addition, they may shed light on molecular and evolutionary aspects of cell-cell recognition mechanisms in other interacting cellular systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI019957-05
Application #
3129408
Study Section
Immunobiology Study Section (IMB)
Project Start
1983-09-01
Project End
1989-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Morteau, Olivier; Gerard, Craig; Lu, Bao et al. (2008) An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol 181:6309-15
Salmi, M; Andrew, D P; Butcher, E C et al. (1995) Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med 181:137-49
Engelhardt, B; Conley, F K; Kilshaw, P J et al. (1995) Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int Immunol 7:481-91
Berlin, C; Bargatze, R F; Campbell, J J et al. (1995) alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-22
Hasslen, S R; von Andrian, U H; Butcher, E C et al. (1995) Spatial distribution of L-selectin (CD62L) on human lymphocytes and transfected murine L1-2 cells. Histochem J 27:547-54
Altevogt, P; Hubbe, M; Ruppert, M et al. (1995) The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1. J Exp Med 182:345-55
Bargatze, R F; Jutila, M A; Butcher, E C (1995) Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 3:99-108
Zannettino, A C; Berndt, M C; Butcher, C et al. (1995) Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 85:3466-77
von Andrian, U H; Hasslen, S R; Nelson, R D et al. (1995) A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell 82:989-99
Zehnder, J L; Shatsky, M; Leung, L L et al. (1995) Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide. Blood 85:1282-8

Showing the most recent 10 out of 81 publications